DFE Pharma, a provider of pharmaceutical excipient solutions, has launched Pharmacel sMCC 90, a silicified microcrystalline cellulose (MCC). Pharmacel sMCC 90 has been developed as the synergistic solution for challenging oral solid dosage formulations. Among several advancements in formulation science, co-processed excipients are gaining popularity as they offer effective means to rapidly develop products for early human trials, while minimizing the risk to product quality.   Accordin...